Ute Schellenberger
Impact in
-
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Oncology top 10%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 11
- CAR-T cell therapy research 4
- Peptidase Inhibition and Analysis 4
-
- Chemical Synthesis and Analysis 8
- Biochemical and Molecular Research 3
- Cell death mechanisms and regulation 3
- Co-authors
- Andrew A. Protter (4 shared papers)Jessica L. O'Rear (4 shared papers)N. Stephen Pollitt (2 shared papers)George F. Schreiner (3 shared papers)Hans‐Dieter Jakubke (9 shared papers)Volker Schellenberger (9 shared papers)Susan C.D. Wright (3 shared papers)James W. Larrick (2 shared papers)
- Journals
- Frontiers in Immunology (3 papers)mAbs (3 papers)Circulation Heart Failure (2 papers)Biotechnology and Bioengineering (2 papers)Circulation (2 papers)
- Partner nations
- United StatesGermanyRussia
In The Last Decade
Ute Schellenberger
41 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 99
- Cardiology and Cardiovascular Medicine 486
- Oncology 320
- Radiology, Nuclear Medicine and Imaging 245
- Molecular Biology 613
- Immunology 139
Countries citing papers authored by Ute Schellenberger
This map shows the geographic impact of Ute Schellenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Schellenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Schellenberger more than expected).
Fields of papers citing papers by Ute Schellenberger
This network shows the impact of papers produced by Ute Schellenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Schellenberger. The network helps show where Ute Schellenberger may publish in the future.
Co-authors
The 25 scholars most cited alongside Ute Schellenberger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 223 | |
| 2 | 2006 | 147 | |
| 3 | 2008 | 146 | |
| 4 | 2011 | 102 | |
| 5 | 2019 | 96 | |
| 6 | 2003 | 94 | |
| 7 | 1997 | 78 | |
| 8 | 2016 | 76 | |
| 9 | 1997 | 71 | |
| 10 | 2021 | 64 | |
| 11 | 1990 | 53 | |
| 12 | 2017 | 40 | |
| 13 | 2019 | 38 | |
| 14 | 2021 | 31 | |
| 15 | 2021 | 30 | |
| 16 | 2002 | 28 | |
| 17 | 1998 | 28 | |
| 18 | 2018 | 27 | |
| 19 | 2022 | 22 | |
| 20 | 1991 | 19 |
About Ute Schellenberger
Ute Schellenberger is a scholar working on Oncology, Molecular Biology, Biotechnology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 41 papers that have together received 1.6k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), CAR-T cell therapy research (4 papers), Peptidase Inhibition and Analysis (4 papers), Biochemical and Molecular Research (3 papers), Cell death mechanisms and regulation (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Enzyme Structure and Function (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (486 citations), Oncology (320 citations), Radiology, Nuclear Medicine and Imaging (245 citations), Molecular Biology (613 citations) and Immunology (139 citations). Ute Schellenberger has collaborated with scholars based in United States, Germany and Russia. Frequent co-authors include Andrew A. Protter, Jessica L. O'Rear, N. Stephen Pollitt, George F. Schreiner, Hans‐Dieter Jakubke, Volker Schellenberger, Susan C.D. Wright, James W. Larrick, Rodney A. Jue and Andrew W. Guzzetta. Their work appears in journals such as Frontiers in Immunology, mAbs, Circulation Heart Failure, Biotechnology and Bioengineering and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.